{"entity":{"type":"insider","cik":"0001564621","url":"/insider/0001564621","json_url":"/insider/0001564621.json","name":"Moriarty John B","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":23,"first":"2014-02-10","last":"2026-01-09","span_basis":"filed_date"},"name_variants":[{"name":"Moriarty John B","source":"filing","n_filings":23,"first_seen":"2014-02-10","last_seen":"2026-01-09"}],"transactions":[{"id":5862956,"accession":"0001599901-26-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599901-26-000011","line_url":"/filing/0001599901-26-000011#line-1","is_derivative":false,"issuer_cik":"0001564621","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001564621","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2374.0,"shares_display":"2,374","price_per_share":72.23,"price_display":"72.23","price_state":"stated","total_value":171474.02,"total_display":"171,474.02","total_whole":"171,474","shares_owned_after":74557.0,"shares_owned_after_display":"74,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-09","scope":"insider"},{"id":5093814,"accession":"0001599901-25-000138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599901-25-000138","line_url":"/filing/0001599901-25-000138#line-1","is_derivative":false,"issuer_cik":"0001564621","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001564621","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2245.0,"shares_display":"2,245","price_per_share":36.21,"price_display":"36.21","price_state":"stated","total_value":81291.45,"total_display":"81,291.45","total_whole":"81,291","shares_owned_after":47755.0,"shares_owned_after_display":"47,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-04","filed_date":"2025-08-05","scope":"insider"},{"id":6538334,"accession":"0000899866-18-000037","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899866-18-000037","line_url":"/filing/0000899866-18-000037","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3363.0,"shares_display":"3,363","price_per_share":115.7,"price_display":"115.70","price_state":"stated","total_value":389099.1,"total_display":"389,099.10","total_whole":"389,099","shares_owned_after":75737.0,"shares_owned_after_display":"75,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-08","filed_date":"2018-02-08","scope":"insider","n_lines":2},{"id":6254291,"accession":"0000899866-18-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-18-000015","line_url":"/filing/0000899866-18-000015#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1261.0,"shares_display":"1,261","price_per_share":117.26,"price_display":"117.26","price_state":"stated","total_value":147864.86,"total_display":"147,864.86","total_whole":"147,865","shares_owned_after":49911.0,"shares_owned_after_display":"49,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":4392273,"accession":"0000899866-17-000060","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899866-17-000060","line_url":"/filing/0000899866-17-000060#line-4","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":282.0,"shares_display":"282","price_per_share":132.5,"price_display":"132.50","price_state":"stated","total_value":37365.0,"total_display":"37,365.00","total_whole":"37,365","shares_owned_after":44672.0,"shares_owned_after_display":"44,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-01","scope":"insider"},{"id":4392270,"accession":"0000899866-17-000060","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-17-000060","line_url":"/filing/0000899866-17-000060#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":910.0,"shares_display":"910","price_per_share":131.71,"price_display":"131.71","price_state":"stated","total_value":119856.1,"total_display":"119,856.10","total_whole":"119,856","shares_owned_after":44954.0,"shares_owned_after_display":"44,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-01","scope":"insider"},{"id":4392256,"accession":"0000899866-17-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000060","line_url":"/filing/0000899866-17-000060#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":612.0,"shares_display":"612","price_per_share":131.2,"price_display":"131.20","price_state":"stated","total_value":80294.4,"total_display":"80,294.40","total_whole":"80,294","shares_owned_after":45864.0,"shares_owned_after_display":"45,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-27","filed_date":"2017-03-01","scope":"insider"},{"id":4769066,"accession":"0000899866-17-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000036","line_url":"/filing/0000899866-17-000036#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":167.0,"shares_display":"167","price_per_share":126.84,"price_display":"126.84","price_state":"stated","total_value":21182.28,"total_display":"21,182.28","total_whole":"21,182","shares_owned_after":46476.0,"shares_owned_after_display":"46,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-02-10","scope":"insider"},{"id":5237851,"accession":"0000899866-17-000029","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-17-000029","line_url":"/filing/0000899866-17-000029#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135.0,"shares_display":"135","price_per_share":128.09,"price_display":"128.09","price_state":"stated","total_value":17292.15,"total_display":"17,292.15","total_whole":"17,292","shares_owned_after":46643.0,"shares_owned_after_display":"46,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-07","filed_date":"2017-02-08","scope":"insider"},{"id":5237841,"accession":"0000899866-17-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-17-000029","line_url":"/filing/0000899866-17-000029","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3403.0,"shares_display":"3,403","price_per_share":125.69466353217749,"price_display":"125.69","price_state":"stated","total_value":427738.94,"total_display":"427,738.94","total_whole":"427,739","shares_owned_after":46801.0,"shares_owned_after_display":"46,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-08","scope":"insider","n_lines":2},{"id":2544312,"accession":"0000899866-16-000391","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000391","line_url":"/filing/0000899866-16-000391#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1044.0,"shares_display":"1,044","price_per_share":118.61,"price_display":"118.61","price_state":"stated","total_value":123828.84,"total_display":"123,828.84","total_whole":"123,829","shares_owned_after":50181.0,"shares_owned_after_display":"50,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-12","filed_date":"2016-12-13","scope":"insider"},{"id":3032967,"accession":"0000899866-16-000341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000341","line_url":"/filing/0000899866-16-000341#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135.0,"shares_display":"135","price_per_share":137.14,"price_display":"137.14","price_state":"stated","total_value":18513.9,"total_display":"18,513.90","total_whole":"18,514","shares_owned_after":51225.0,"shares_owned_after_display":"51,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-08","filed_date":"2016-08-10","scope":"insider"},{"id":2943225,"accession":"0000899866-16-000324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000324","line_url":"/filing/0000899866-16-000324#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":918.0,"shares_display":"918","price_per_share":135.72,"price_display":"135.72","price_state":"stated","total_value":124590.96,"total_display":"124,590.96","total_whole":"124,591","shares_owned_after":51360.0,"shares_owned_after_display":"51,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-13","filed_date":"2016-06-14","scope":"insider"},{"id":2943219,"accession":"0000899866-16-000267","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-16-000267","line_url":"/filing/0000899866-16-000267","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1201.0,"shares_display":"1,201","price_per_share":138.9114487926728,"price_display":"138.91","price_state":"stated","total_value":166832.65,"total_display":"166,832.65","total_whole":"166,833","shares_owned_after":52279.0,"shares_owned_after_display":"52,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-29","filed_date":"2016-03-01","scope":"insider","n_lines":2},{"id":2863364,"accession":"0000899866-16-000247","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899866-16-000247","line_url":"/filing/0000899866-16-000247","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2633.0,"shares_display":"2,633","price_per_share":138.084876566654,"price_display":"138.08","price_state":"stated","total_value":363577.48,"total_display":"363,577.48","total_whole":"363,577","shares_owned_after":48501.0,"shares_owned_after_display":"48,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-08","filed_date":"2016-02-08","scope":"insider","n_lines":3},{"id":2863348,"accession":"0000899866-16-000247","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899866-16-000247","line_url":"/filing/0000899866-16-000247","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1969.0,"shares_display":"1,969","price_per_share":143.4470441848654,"price_display":"143.45","price_state":"stated","total_value":282447.23,"total_display":"282,447.23","total_whole":"282,447","shares_owned_after":52603.0,"shares_owned_after_display":"52,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-05","filed_date":"2016-02-08","scope":"insider","n_lines":5},{"id":8170710,"accession":"0000899866-15-000210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-15-000210","line_url":"/filing/0000899866-15-000210","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":943.0,"shares_display":"943","price_per_share":182.72661717921528,"price_display":"182.73","price_state":"stated","total_value":172311.2,"total_display":"172,311.20","total_whole":"172,311","shares_owned_after":41365.0,"shares_owned_after_display":"41,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-11","filed_date":"2015-12-15","scope":"insider","n_lines":2},{"id":8170688,"accession":"0000899866-15-000155","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000155","line_url":"/filing/0000899866-15-000155#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135.0,"shares_display":"135","price_per_share":190.01,"price_display":"190.01","price_state":"stated","total_value":25651.35,"total_display":"25,651.35","total_whole":"25,651","shares_owned_after":42283.0,"shares_owned_after_display":"42,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-07","filed_date":"2015-08-11","scope":"insider"},{"id":8482458,"accession":"0000899866-15-000142","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899866-15-000142","line_url":"/filing/0000899866-15-000142","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10010.0,"shares_display":"10,010","price_per_share":198.43922877122878,"price_display":"198.44","price_state":"stated","total_value":1986376.68,"total_display":"1,986,376.68","total_whole":"1,986,377","shares_owned_after":35854.0,"shares_owned_after_display":"35,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-05","filed_date":"2015-08-05","scope":"insider","n_lines":2},{"id":8875330,"accession":"0000899866-15-000127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000127","line_url":"/filing/0000899866-15-000127#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":914.0,"shares_display":"914","price_per_share":170.0,"price_display":"170.00","price_state":"stated","total_value":155380.0,"total_display":"155,380.00","total_whole":"155,380","shares_owned_after":32428.0,"shares_owned_after_display":"32,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-11","filed_date":"2015-06-12","scope":"insider"},{"id":8895026,"accession":"0000899866-15-000074","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-15-000074","line_url":"/filing/0000899866-15-000074#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":280.0,"shares_display":"280","price_per_share":180.34,"price_display":"180.34","price_state":"stated","total_value":50495.2,"total_display":"50,495.20","total_whole":"50,495","shares_owned_after":33342.0,"shares_owned_after_display":"33,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-03","scope":"insider"},{"id":8686753,"accession":"0000899866-15-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000051","line_url":"/filing/0000899866-15-000051#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1490.0,"shares_display":"1,490","price_per_share":171.15,"price_display":"171.15","price_state":"stated","total_value":255013.5,"total_display":"255,013.50","total_whole":"255,014","shares_owned_after":26777.0,"shares_owned_after_display":"26,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-10","filed_date":"2015-02-12","scope":"insider"},{"id":8075085,"accession":"0000899866-15-000034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-15-000034","line_url":"/filing/0000899866-15-000034#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1455.0,"shares_display":"1,455","price_per_share":174.16,"price_display":"174.16","price_state":"stated","total_value":253402.8,"total_display":"253,402.80","total_whole":"253,403","shares_owned_after":28267.0,"shares_owned_after_display":"28,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-09","filed_date":"2015-02-09","scope":"insider"},{"id":6301846,"accession":"0000899866-14-000265","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-14-000265","line_url":"/filing/0000899866-14-000265#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3570.0,"shares_display":"3,570","price_per_share":195.53,"price_display":"195.53","price_state":"stated","total_value":698042.1,"total_display":"698,042.10","total_whole":"698,042","shares_owned_after":20962.0,"shares_owned_after_display":"20,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-15","scope":"insider"},{"id":6924540,"accession":"0000899866-14-000230","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-14-000230","line_url":"/filing/0000899866-14-000230","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":189.493723,"price_display":"189.49","price_state":"stated","total_value":1894937.23,"total_display":"1,894,937.23","total_whole":"1,894,937","shares_owned_after":24605.0,"shares_owned_after_display":"24,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-27","filed_date":"2014-10-28","scope":"insider","n_lines":2},{"id":6597716,"accession":"0000899866-14-000218","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-14-000218","line_url":"/filing/0000899866-14-000218#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":179.0,"price_display":"179.00","price_state":"stated","total_value":1790000.0,"total_display":"1,790,000.00","total_whole":"1,790,000","shares_owned_after":24532.0,"shares_owned_after_display":"24,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-06","filed_date":"2014-10-08","scope":"insider"},{"id":6480794,"accession":"0000899866-14-000045","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-14-000045","line_url":"/filing/0000899866-14-000045","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001564621","owner_name":"Moriarty John B","owner_display_name":"Moriarty John B","owner_url":"/insider/0001564621","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1036.0,"shares_display":"1,036","price_per_share":155.5964864864865,"price_display":"155.60","price_state":"stated","total_value":161197.96,"total_display":"161,197.96","total_whole":"161,198","shares_owned_after":22248.0,"shares_owned_after_display":"22,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-07","filed_date":"2014-02-10","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001599901","name":"Avidity Biosciences, Inc.","url":"/issuer/0001599901","role":"Officer (Chief Legal Officer)","n_filings":2,"first_seen":"2025-08-05","last_seen":"2026-01-09"},{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Officer (EVP & General Counsel)","n_filings":21,"first_seen":"2014-02-10","last_seen":"2018-02-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001564621","retrieved_at":"2026-08-26T23:11:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}